Invention Grant
- Patent Title: CGRP receptor antagonists
-
Application No.: US15882038Application Date: 2018-01-29
-
Publication No.: US10166226B2Publication Date: 2019-01-01
- Inventor: John Andrew Christopher , Miles Stuart Congreve , Sarah Joanne Bucknell , Francesca Deflorian , Mark Pickworth , Jonathan Stephen Mason
- Applicant: Heptares Therapeutics Limited
- Applicant Address: GB Welwyn Garden City
- Assignee: Heptares Therapeutics Limited
- Current Assignee: Heptares Therapeutics Limited
- Current Assignee Address: GB Welwyn Garden City
- Agency: McCarter & English, LLP
- Agent Steven G. Davis; Mei Bai
- Priority: GB1519194.3 20151030
- Main IPC: C07D401/14
- IPC: C07D401/14 ; A61K31/4709
Abstract:
The disclosures herein relate to novel compounds of formula wherein Ar1 and R1 are as defined herein, and their use in treating, preventing, ameliorating, controlling or reducing cerebrovascular or vascular disorders associated with CGRP receptor function.
Public/Granted literature
- US20180153876A1 CGRP Receptor Antagonists Public/Granted day:2018-06-07
Information query
